Cancer Stem Cell News Volume 9.36 | Sep 23 2020

    0
    4







    2020-23-09 | CSC 9.36


    Cancer Stem Cell News by STEMCELL Technologies
    Vol. 9.36 – 23 September, 2020
    TOP STORY

    The Lysophospholipase D Enzyme Gdpd3 Is Required to Maintain Chronic Myelogenous Leukemia Stem Cells

    Investigators showed that disruption of the Gdpd3 gene encoding a lysophospholipase D enzyme significantly decreased self-renewal capacity in murine chronic myelogenous leukemia stem cells in vivo.
    [Nature Communications]

    Full ArticlePress Release
    Explore virtual support and resources to stay productive and connected with your field.
    PUBLICATIONSRanked by the impact factor of the journal

    SPT6-Driven Error-Free DNA Repair Safeguards Genomic Stability of Glioblastoma Cancer Stem-Like Cells

    Researchers presented the results of a high-content siRNA microscopy screen, revealing the transcriptional elongation factor SPT6 to be critical for the genomic stability and self-renewal of glioblastoma cancer-stem like cells.
    [Nature Communications]

    Full Article

    LncRNA HotairM1 Depletion Promotes Self-Renewal of Cancer Stem Cells through HOXA1-Nanog Regulation Loop

    Based on analysis of transcriptome sequencing, scientists identified a long noncoding RNA (lncRNA) named HotairM1 that was weakly expressed in human colorectal carcinoma and uveal melanoma, and a much lower expression in corresponding CSCs.
    [Molecular Therapy-Nucleic Acids]

    AbstractFull ArticleGraphical Abstract

    Exosomal LncRNA DOCK9-AS2 Derived from Cancer Stem Cell-Like Cells Activated Wnt/β-Catenin Pathway to Aggravate Stemness, Proliferation, Migration, and Invasion in Papillary Thyroid Carcinoma

    DOCK9-AS2 knockdown reduced proliferation, migration, invasion, epithelial-to-mesenchymal and stemness in papillary thyroid carcinoma cells.
    [Cell Death & Disease]

    Full Article

    Wnt/β-Catenin Signaling Pathway Induces Autophagy-Mediated Temozolomide-Resistance in Human Glioblastoma

    Investigators demonstrated that the loss of DOC-2/DAB2 interacting protein (DAB2IP) was responsible for temozolomide (TMZ)-resistance in glioblastoma multiforme (GBM) through ATG9B. DAB2IP sensitized GBM to TMZ and suppressed TMZ-induced autophagy by negatively regulating ATG9B expression.
    [Cell Death & Disease]

    Full Article

    A Myristoyl Amide Derivative of Doxycycline Potently Targets Cancer Stem Cells (CSCs) and Prevents Spontaneous Metastasis, without Retaining Antibiotic Activity

    Researchers described the chemical synthesis and biological activity of a new doxycycline derivative, designed specifically to more effectively target CSCs.
    [Frontiers in Oncology]

    Full Article

    Attenuating Hypoxia Driven Malignant Behavior in Glioblastoma with a Novel Hypoxia-Inducible Factor 2 Alpha Inhibitor

    Scientists investigated a novel hypoxia inducible factor2α inhibitor, PT2385, both in vitro, with low-passage patient-derived cell lines, and in vivo, using orthotopic models of glioblastoma.
    [Scientific Reports]

    Full Article

    Quantitative In Vivo Bioluminescence Imaging of Orthotopic Patient-Derived Glioblastoma Xenografts

    The authors showed that stable expression of near-infrared fluorescent protein in patient-derived glioblastoma cells enabled rapid, direct non-invasive monitoring of tumor development without compromising tumor stemness or tumorigenicity.
    [Scientific Reports]

    Full Article

    Methionine Represses the Autophagy of Gastric Cancer Stem Cells via Promoting the Methylation and Phosphorylation of RAB37

    Scientists focused on the role of methionine in the autophagy of gastric cancer stem cells and elaborated its regulatory mechanism.
    [Cell Cycle]

    Abstract

    Matrix Metalloprotease-7 Mediates Nucleolar Assembly & Intra-Nucleolar Cleaving p53 in Gefitinib Resistant Cancer Stem Cells

    Investigators showed that matrix metalloproteinase-7 shedding MUC-1 SEA domain releases MUC-1 C-ter facilitating the nucleolus trafficking of p53 in gefitinib-resistant lung cancer stem cells.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    REVIEWS

    The Role of Breast Cancer Stem Cell-Related Biomarkers as Prognostic Factors

    The cell-surface and subcellular biomarkers related to breast cancer stem cell (BCSC) phenotypes are increasingly being recognised. These biomarkers are useful for the isolation of BCSCs and can serve as potential therapeutic targets and prognostic tools to monitor treatment responses.
    [Diagnostics ]

    Full Article

    The Role of Smoothened in Cancer

    Smoothened (SMO) expression correlates with tumor size, invasiveness, metastasis and recurrence. In addition, SMO inhibitors can suppress cancer formation, reduce the proliferation of cancer cells, trigger apoptosis and suppress cancer stem cell activity.
    [International Journal of Medical Sciences]

    Full Article

    INDUSTRY AND POLICY NEWS

    Jazz Pharmaceuticals Launches Initiative to Help Educate People Living with Rare Form of Leukemia

    Jazz Pharmaceuticals plc announced the launch of Find the Right Fit, a US patient education program developed in consultation with the Myelodysplastic Syndromes (MDS) Foundation, Inc. and the Cancer Support Community focused on empowering people affected by secondary acute myeloid leukemia and MDS.
    [Jazz Pharmaceuticals plc]

    Press Release

    NIH Funds Research into Differences in Glioblastoma between Males and Females

    A team led by researchers from Case Western Reserve University School of Medicine and Cleveland Clinic’s Lerner Research Institute has secured $10.4 million over five years from the National Institutes of Health/National Cancer Institute to explore at the molecular level the differences in glioblastoma between males and females.
    [Cleveland Clinic Lerner Research Institute]

    Press Release

    FEATURED EVENT

    10 Million Reasons to Defeat Cancer 2020 – Abbott World Summit

    October 13 – October 14
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Stem Cells and Cancer

    Albert Einstein College of Medicine – New York, New York, United States

    Assistant/Associate Professor – Center for Molecular Medicine

    The University of Georgia – Athens, Georgia, United States

    Postdoctoral Position – Cancer Stem Cell Biology

    Karolinska Institute – Solna, Sweden

    Postdoctoral Position – Human Pluripotent Stem Cells, Hematopoiesis and Leukemia

    Icahn School of Medicine at Mount Sinai – New York City, New York, United States

    Postdoctoral Fellow – Immunology, Genetics, Precision Medicine

    St. Anna Children’s Cancer Research Institute – Vienna, Austria

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Cancer Stem Cell News Archives Contact Us
    Cancer Stem Cell News Twitter